Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1995 1
2003 1
2004 1
2005 1
2006 4
2007 2
2008 4
2009 2
2011 1
2012 6
2013 3
2014 1
2015 5
2016 4
2017 3
2018 1
2019 2
2020 7
2021 5
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Results by year
Filters applied: . Clear all
Page 1
Phase separation drives aberrant chromatin looping and cancer development.
Ahn JH, Davis ES, Daugird TA, Zhao S, Quiroga IY, Uryu H, Li J, Storey AJ, Tsai YH, Keeley DP, Mackintosh SG, Edmondson RD, Byrum SD, Cai L, Tackett AJ, Zheng D, Legant WR, Phanstiel DH, Wang GG. Ahn JH, et al. Among authors: uryu h. Nature. 2021 Jul;595(7868):591-595. doi: 10.1038/s41586-021-03662-5. Epub 2021 Jun 23. Nature. 2021. PMID: 34163069 Free PMC article.
The clonal evolution during long-term clinical course of multiple myeloma.
Mishima Y, Mishima Y, Shirouchi Y, Nishimura N, Yokoyama M, Okabe T, Inoue N, Uryu H, Fukuta T, Hatake K, Terui Y. Mishima Y, et al. Among authors: uryu h. Int J Hematol. 2021 Feb;113(2):279-284. doi: 10.1007/s12185-020-02979-7. Epub 2020 Aug 30. Int J Hematol. 2021. PMID: 32864713
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion.
Koss B, Shields BD, Taylor EM, Storey AJ, Byrum SD, Gies AJ, Washam CL, Choudhury SR, Hyun Ahn J, Uryu H, Williams JB, Krager KJ, Chiang TC, Mackintosh SG, Edmondson RD, Aykin-Burns N, Gajewski TF, Wang GG, Tackett AJ. Koss B, et al. Among authors: uryu h. Cancer Res. 2020 Nov 1;80(21):4707-4719. doi: 10.1158/0008-5472.CAN-20-0524. Epub 2020 Oct 1. Cancer Res. 2020. PMID: 33004350 Free PMC article.
Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma.
Uryu H, Mishima Y, Tsuyama N, Yokoyama M, Nishimura N, Fukuta T, Shirouchi Y, Okabe T, Inoue N, Takeuchi K, Terui Y. Uryu H, et al. Leuk Lymphoma. 2021 Sep;62(9):2141-2150. doi: 10.1080/10428194.2021.1901091. Epub 2021 Mar 21. Leuk Lymphoma. 2021. PMID: 33749498
Comprehensive structure-function characterization of DNMT3B and DNMT3A reveals distinctive de novo DNA methylation mechanisms.
Gao L, Emperle M, Guo Y, Grimm SA, Ren W, Adam S, Uryu H, Zhang ZM, Chen D, Yin J, Dukatz M, Anteneh H, Jurkowska RZ, Lu J, Wang Y, Bashtrykov P, Wade PA, Wang GG, Jeltsch A, Song J. Gao L, et al. Among authors: uryu h. Nat Commun. 2020 Jul 3;11(1):3355. doi: 10.1038/s41467-020-17109-4. Nat Commun. 2020. PMID: 32620778 Free PMC article.
Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population.
Shirouchi Y, Yokoyama M, Fukuta T, Uryu H, Nishimura N, Mishima Y, Inoue N, Tsuyama N, Takeuchi K, Terui Y. Shirouchi Y, et al. Among authors: uryu h. Leuk Lymphoma. 2021 Aug;62(8):1869-1876. doi: 10.1080/10428194.2021.1894649. Epub 2021 Mar 10. Leuk Lymphoma. 2021. PMID: 33688781
Improvement in recurrent anti-myelin oligodendrocyte glycoprotein antibody - positive cerebral cortical encephalitis not requiring anti - inflammatory therapy following the decrease in cytokine/chemokine levels.
Takamatsu T, Yamanaka G, Uryu H, Takeshita M, Morishita N, Morichi S, Ishida Y, Oana S, Terashi H, Shichino H, Sakuma H, Kawashima H. Takamatsu T, et al. Among authors: uryu h. Mult Scler Relat Disord. 2020 Aug;43:102168. doi: 10.1016/j.msard.2020.102168. Epub 2020 May 12. Mult Scler Relat Disord. 2020. PMID: 32434135 No abstract available.
56 results